Search results
Two Special Issues are coming in 2025: New Anticancer Agents – 2025 (Submission deadline: May 10, 2025; Publication date: July 2025). Click here for more information. Advances in Renal Cell Carcinoma Diagnosis and Treatment – 2025 (Submission deadline: July 10, 2025; Publication date: October 2025). Click here for more information.
- Archive
Immunoliposomes for Neuroblastoma: Review of the Past...
- Other Publications
Journal Metrics; Other Publications. In Vivo; Cancer...
- About Us
ANTICANCER RESEARCH is an independent international...
- Subscribers
If you have any questions related to your online...
- Advertisers
We strongly believe that ANTICANCER RESEARCH can serve as a...
- Editorial Board
Section for Experimental Cancer Research, Clinical Research...
- In Vivo
Three Special Issues are coming in 2025: Circulating Tumor...
- Cancer Genomics & Proteomics
Two Special Issues are coming in 2025: Cancer Invasion and...
- Archive
Anticancer Research is an international journal designed to rapidly publish original papers and reviews on experimental and clinical cancer research. Anticancer Research was established in 1981 by J.G. Delinasios.
Type a term to search within all articles in this journal: e.g., stem cell. Citation.
Comparison of the Predictive and Prognostic Capacities of Neutrophil, Lymphocyte and Platelet Counts and Tumor-infiltrating Lymphocytes in Triple-negative Breast Cancer: Preliminary Results of the PERCEPTION Study.
Anticancer Research is an international print and online monthly journal designed to rapidly publish peer-reviewed original works and reviews on all aspects of experimental and clinical cancer research.
Anticancer Research, In Vivo, Cancer Genomics & Proteomics, and Cancer Diagnosis & Prognosis are independent international journals, published by the International Institute of Anticancer Research (IIAR), and have had no relation or association with other publishers since their establishment.
ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology.